Scorpio Biotechnology Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
as on 09-07-2024
- Paid Up Capital ₹ 2.62 Cr
as on 09-07-2024
- Company Age 19 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 26.30 Cr
as on 09-07-2024
- Revenue %
(FY 2021)
- Profit -291458.76%
(FY 2021)
- Ebitda -30.83%
(FY 2021)
- Net Worth -79.61%
(FY 2021)
- Total Assets -50.89%
(FY 2021)
About Scorpio Biotechnology
The Company is engaged in the Manufacturing Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 2.62 Cr.
The company currently has active open charges totaling ₹26.30 Cr.
Madhu Agarwal and Ratan Agarwal serve as directors at the Company.
- CIN/LLPIN
U24234UP2005PTC044055
- Company No.
044055
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Sep 2005
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Kanpur Nagar, Uttar Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Scorpio Biotechnology?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Madhu Agarwal  | Additional Director | 07-Mar-2022 | Current |
| Ratan Agarwal | Director | 07-Jun-2017 | Current |
Financial Performance and Corporate Structure Insights of Scorpio Biotechnology.
Scorpio Biotechnology Private Limited, for the financial year ended 2021, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 291458.76% decrease in profit. The company's net worth observed a substantial decline by a decrease of 79.61%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Scorpio Biotechnology?
In 2021, Scorpio Biotechnology had a public holding of 99.99%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Syndicate Bank Creation Date: 26 May 2014 | ₹15.00 Cr | Open |
Central Bank Of India Creation Date: 11 Mar 2014 | ₹11.30 Cr | Open |
How Many Employees Work at Scorpio Biotechnology?
Unlock and access historical data on people associated with Scorpio Biotechnology, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Scorpio Biotechnology, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Scorpio Biotechnology's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
